Our in vitro studies showed that bortezomib downregulates NFκB, blocks constitutive and MM cell adhesion-induced cytokine secretion in BMSCs and induces apoptosis in both MM cell lines and freshly isolated MM cells from patients [35,51]. This evidence concerns the gene NFKB1 and Miyoshi myopathy.